Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05489068 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Motivational Interviewing at Intake vs Intake as Usual on Client Engagement in Addiction Treatment

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 9, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Study site revisedv6 See this version in full on ClinicalTrials.gov ↗
  2. Re-verified, no change to tracked fieldsv5
  3. Primary completion date: Oct 2024 to Oct 1, 2026 Completion date: Dec 2024 to Dec 1, 2026v4 Show 1 more changeShow less
    • Completion date: Dec 2024 to Dec 1, 2026
  4. 2 versions Re-verified since May 8, 2023, no change to tracked fieldsv2-v3
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This K23 study is an effectiveness-implementation hybrid type I design to determine the effectiveness of Motivational Interviewing at Intake (MII), relative to intake-as-usual on client engagement and mechanisms of engagement among adults seeking outpatient addiction treatment. We also will obtain personnel feedback on the feasibility of implementing MII into standard practice by having personnel from the addiction treatment study sites complete implementation climate measures before Motivational Interviewing (MI) training and post-clinical trial, as well as an individual interview on implementation feasibility post-trial.
Trial Details
NCT Number NCT05489068
Lead Sponsor University of New Mexico
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Substance-Related Disorders, Treatment Adherence
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov